- 1. 63-Desulfohirudin(Hirudo medicinalis isoform HV1)
- [A synthetic recombinant form of the naturally occurring hirudin, the anticoagulant substance found in leech. Desirudin is a selective and almost irreversible inhibitor of thrombin, both free and clot-bound, by blocking its active site. This anticoagulant agent has no effect on other components of the hemostatic system. Desirudin is particularly used to prevent deep vein thrombosis in patients undergoing hip and knee replacement surgery. ( NCI )] (UMLS (NCI) C0378366) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 51. desmosome
- [Desmosomes are intercellular anchoring junctions that anchor intermediate filaments at membrane-associated plaques in adjoining cells. Desmosomes assemble in response to cell-cell contact and raised levels of extracellular calcium. Sensitivity to calcium levels is lost as desmosomes mature. ( NCI )] (UMLS (CSP) C0011703) =Cell Component
|
- 2. Desacetyl Colchicine D-tartrate
- (UMLS (NCI) C0338102) =Organic Chemical; Pharmacologic Substance
| - 52. DESONIDE
- [A synthetic glucocorticosteroid for topical use, with anti-inflammatory activity. Desonide binds to glucocorticoid receptors in the cytoplasm, and the ligand-receptor complex is translocated as a homodimer into the nucleus, where transcription activation via glucocorticoid response elements within glucocorticoid-responsive genes occur. This agent induces transcription of genes coding for anti-inflammatory proteins, including lipocortin-1, interleukin-10, interleukin-1 receptor antagonist and neutral endopeptidase. Increased synthesis of lipocortin-1 has an inhibitory effect on phospholipase A2, which in turn inhibits the release arachidonic acid, thereby controlling the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. ( NCI )] (UMLS (NCI) C0011705) =Steroid; Pharmacologic Substance ;
=Pregnadienetriols;
[DE200] ANTI-INFLAMMATORY, TOPICAL =DESONIDE 0.05 % |
- 3. Desacetyl Vinblastine Amide Sulfate
- [The sulfate salt form of Vindesine. Vindesine binds to and stabilizes tubulin, thereby interrupting tubulin polymerization and preventing the formation of the mitotic spindle and cell division; treated cells are unable to undergo mitosis and are arrested in metaphase. This agent also disrupts macromolecular synthesis. (NCI) ( NCI )] (UMLS (NCI) C0042683) =Organic Chemical; Pharmacologic Substance ;
| - 53. Desoxycorticosterone Acetate
- (UMLS (NCI) C0813203) DESOXYCORTICOSTERONE ACETATE PREPARATION =Steroid; Pharmacologic Substance; Hormone =deoxycorticosterone;
deoxycortone pivalate |
- 4. DeSanctis Cacchione syndrome
- [ ] (UMLS (CSP) C0265201) =Congenital Abnormality ;
| - 54. Desoxyn
- (UMLS (NCI) C0728809) =Organic Chemical; Pharmacologic Substance ;
|
- 5. desaturase
- [ ] (UMLS (CSP) C0599871) =Amino Acid, Peptide, or Protein; Enzyme
| - 55. Desquamative Interstitial Pneumonia
- (UMLS (NCI) C0238378) =Disease or Syndrome
|
- 6. Desc
- [A written or verbal account, representation, statement, or explanation of something. ( NCI )] (UMLS (NCI) C0678257) =Idea or Concept ;
=MDFAttributeType;
| - 56. destination
- [The destination for services. May be a static building (or room therein) or a movable facility (e.g., ship). ( HL7V3.0 )] (UMLS (HL7) C0079220) =Spatial Concept =location;
|
- 7. Descemet's Membrane
- [A thin hyaline membrane between the chief part of the sclera and the endothelial layer of the cornea. ( NCI )] (UMLS (NCI) C0011665) =Body Part, Organ, or Organ Component ;
| - 57. DESTR INJECT-SPINE CANAL
- [ ] (UMLS (ICD9CM) C0196504) =Therapeutic or Preventive Procedure
|
- 8. DESCEMETOCELE
- [ ] (UMLS (ICD9CM) C0155136) =Anatomical Abnormality
| - 58. DESTR PHREN-LUNG COLLAPS
- [ ] (UMLS (ICD9CM) C0176516) =Therapeutic or Preventive Procedure
|
- 9. Descend
- [To travel downward. ( NCI )] (UMLS (NCI) C0205386) =Qualitative Concept
| - 59. DESTR SM BOWEL LES NEC
- [ ] (UMLS (ICD9CM) C0176795) =Therapeutic or Preventive Procedure
|
- 10. Descending
- [Descending sequence order. ( HL7V3.0 )] (UMLS (HL7) C1547177) =Qualitative Concept =Sequencing;
Sequencing | - 60. destrin
- [A member of the actin depolymerizing factors. Its depolymerizing activity is independent of HYDROGEN-ION CONCENTRATION. ( MSH )] (UMLS (CSP) C0962546) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 11. Descending Aorta
- (UMLS (NCI) C0011666) =Body Part, Organ, or Organ Component ;
| - 61. DESTROY FALLOP TUBE LES
- (UMLS (ICD9CM) C0195505) =Therapeutic or Preventive Procedure
|
- 12. Descending Colon
- [The fourth portion of the large intestine (colon) that communicates with the transverse colon in the left-upper quadrant of the abdomen and the rectum below. ( NCI )] (UMLS (NCI) C0227389) =Body Part, Organ, or Organ Component
| - 62. DESTROY LOC LUNG LES NEC
- [ ] (UMLS (ICD9CM) C0176505) =Therapeutic or Preventive Procedure
|
- 13. DESCENDING COLON INJ-CL
- [ ] (UMLS (ICD9CM) C0160360) =Injury or Poisoning
| - 63. DESTRUC BARTHOLIN GLAND
- [ ] (UMLS (ICD9CM) C0177248) =Therapeutic or Preventive Procedure
|
- 14. DESCENDING COLON INJ-OPN
- [ ] (UMLS (ICD9CM) C0160369) =Injury or Poisoning
| - 64. DESTRUC HEPATIC LES NEC
- [ ] (UMLS (ICD9CM) C0176883) =Therapeutic or Preventive Procedure
|
- 15. Descending Limb of Henle's Loop
- (UMLS (NCI) C0227657) =Body Part, Organ, or Organ Component
| - 65. DESTRUC LG BOWEL LES NEC
- [ ] (UMLS (ICD9CM) C0176799) =Therapeutic or Preventive Procedure
|
- 16. Descending Portion of Duodenum
- (UMLS (NCI) C0227301) =Body Part, Organ, or Organ Component
| - 66. DESTRUC UTER SUPPORT NEC
- [ ] (UMLS (ICD9CM) C0177206) =Therapeutic or Preventive Procedure
|
- 17. Descending Spinal Cord Tract
- (UMLS (NCI) C1282011) Descending Spinal Tracts =Body Part, Organ, or Organ Component
| - 67. DESTRUC-ANKLE LESION NEC
- [ ] (UMLS (ICD9CM) C0177528) =Therapeutic or Preventive Procedure
|
- 18. Descending, case insensitive
- (UMLS (HL7) C1547178) =Idea or Concept =Sequencing;
| - 68. DESTRUC-ELBOW LESION NEC
- [ ] (UMLS (ICD9CM) C0177523) =Therapeutic or Preventive Procedure
|
- 19. described
- [The described determiner is used to indicate that the given Entity is taken as a general description of a kind of thing that can be taken in whole, in part, or in multiples. ( HL7V3.0 )] (UMLS (HL7) C1552738) =Idea or Concept =EntityDeterminer;
=described quantified;
| - 69. DESTRUC-FOOT JT LES NEC
- [ ] (UMLS (ICD9CM) C0177529) =Therapeutic or Preventive Procedure
|
- 20. described quantified
- [The described quantified determiner indicates that the given Entity is taken as a general description of a specific amount of a thing. For example, QUANTIFIED_KIND of syringe (quantity = 3,) stands for exactly three syringes. ( HL7V3.0 )] (UMLS (HL7) C1552739) =Idea or Concept =described;
| - 70. DESTRUC-HAND JT LES NEC
- [ ] (UMLS (ICD9CM) C0177525) =Therapeutic or Preventive Procedure
|
- 21. Descriptor
- [One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing. ( NCI )] (UMLS (NCI) C0600091) =Intellectual Product ;
| - 71. DESTRUC-SHOULDER LES NEC
- [ ] (UMLS (ICD9CM) C0177522) =Therapeutic or Preventive Procedure
|
- 22. DESENSITIZA TO ALLERGENS
- [ ] (UMLS (ICD9CM) C0260398) =Finding
| - 72. DESTRUC-WRIST LESION NEC
- [ ] (UMLS (ICD9CM) C0177524) =Therapeutic or Preventive Procedure
|
- 23. Desensitization
- [prevention or reduction of hypersensitivity reactions by administration of graded doses of allergen. ( CSP )] (UMLS (NCI) C0178702) =Therapeutic or Preventive Procedure =Anti-Rejection Therapy;
| - 73. DESTRUCT ABD WALL LESION
- [ ] (UMLS (ICD9CM) C0176973) =Therapeutic or Preventive Procedure
|
- 24. desensitization psychotherapy
- [treatment of phobias and related disorders by intentionally exposing the patient, in imagination or real life, to emotionally distressing stimuli. ( CSP )] (UMLS (CSP) C0556520) =Therapeutic or Preventive Procedure =Behavior Conditioning Therapy;
| - 74. DESTRUCT CHEST WALL LES
- [ ] (UMLS (ICD9CM) C0176536) =Therapeutic or Preventive Procedure
|
- 25. DESERPIDINE
- [An ester alkaloid derived from Rauwolfia canescens with antihypertensive activity. Deserpidine is a competitive inhibitor of the angiotensin converting enzyme (ACE). By competing with angiotensin I for ACE, deserpidine blocks the conversion of angiotensin I to angiotensin II, which is a potent vasoconstrictor. Reduced level of serum angiotensin II causes a decrease in blood pressure. Deserpidine also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex. ( NCI )] (UMLS (NCI) C0175158) =Organic Chemical; Pharmacologic Substance =(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic Acid Methyl Ester;
[CV490] ANTIHYPERTENSIVES, OTHER =DESERPIDINE 0.5 MG;
DESERPIDINE 0.25 MG;
| - 75. DESTRUCT CONJUNC LES NEC
- [ ] (UMLS (ICD9CM) C0197372) =Therapeutic or Preventive Procedure ;
|
- 26. desert fever
- [ ] (UMLS (CSP) C0153257) =Disease or Syndrome
| - 76. DESTRUCT CORNEA LES NEC
- [ ] (UMLS (ICD9CM) C0176212) =Therapeutic or Preventive Procedure
|
- 27. Desferal
- (UMLS (NCI) C0591350) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid
| - 77. DESTRUCT DUODEN LES NEC
- [ ] (UMLS (ICD9CM) C0176793) =Therapeutic or Preventive Procedure
|
- 28. Designated current drug or biological payment adjustment applies to APC (status indicator G)
- (UMLS (HL7) C1547513) =Intellectual Product =Payment Adjustment Code;
| - 78. DESTRUCT ESOPHAG LES NEC
- [ ] (UMLS (ICD9CM) C0176732) =Therapeutic or Preventive Procedure
|
- 29. Designated new device payment adjustment applies to APC (status indicator H)
- (UMLS (HL7) C1547514) =Intellectual Product =Payment Adjustment Code;
| - 79. DESTRUCT EXT EAR LES NEC
- [ ] (UMLS (ICD9CM) C0176317) =Therapeutic or Preventive Procedure
|
- 30. Designated new drug or new biological payment adjustment applies to APC (status indicator J)
- (UMLS (HL7) C1547515) =Intellectual Product =Payment Adjustment Code;
| - 80. DESTRUCT FACIAL BONE LES
- [ ] (UMLS (ICD9CM) C0177300) =Therapeutic or Preventive Procedure
|
- 31. designer antibody
- [ ] (UMLS (CSP) C0598623) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
| - 81. DESTRUCT JOINT LES NEC
- [ ] (UMLS (ICD9CM) C0177530) =Therapeutic or Preventive Procedure
|
- 32. desipramine
- [tricyclic dibenzazepine compound that potentiates neurotransmission; desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport; this compound also possesses minor anticholingeric activity, through its affinity to muscarinic receptors. ( CSP )] (UMLS (CSP) C0011685) =Organic Chemical; Pharmacologic Substance =[CN601] TRICYCLIC ANTIDEPRESSANTS;
azepine;
Dibenzazepines;
=DESIPRAMINE HYDROCHLORIDE | - 82. DESTRUCT JOINT LES NOS
- [ ] (UMLS (ICD9CM) C0376075) =Therapeutic or Preventive Procedure
|
- 33. desire
- [ ] (UMLS (CSP) C0871633) =Mental Process; Individual Behavior
| - 83. DESTRUCT LARYNX LES NEC
- [ ] (UMLS (ICD9CM) C0176471) =Therapeutic or Preventive Procedure
|
- 34. DESLANOSIDE
- [Deacetyllanatoside C. A cardiotonic glycoside from the leaves of Digitalis lanata. ( MSH )] (UMLS (NCI) C0011689) =Carbohydrate; Pharmacologic Substance =[CV050] DIGITALIS GLYCOSIDES;
Lanatosides | - 84. DESTRUCT MEDIASTIN LES
- [ ] (UMLS (ICD9CM) C0701828) =Therapeutic or Preventive Procedure
|
- 35. Deslorelin Acetate
- (UMLS (NCI) C0378714) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 85. DESTRUCT PERITONEAL TISS
- [ ] (UMLS (ICD9CM) C0176974) =Therapeutic or Preventive Procedure
|
- 36. desmin
- [An intermediate filament protein found predominantly in smooth, skeletal, and cardiac muscle cells. Localized at the Z line. MW 50,000 to 55,000 is species dependent. ( MSH )] (UMLS (CSP) C0011696) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 86. DESTRUCT SCLERAL LESION
- [ ] (UMLS (ICD9CM) C0176235) =Therapeutic or Preventive Procedure
|
- 37. desmocollin
- [A group of desmosomal cadherins with cytoplasmic tails that are divergent from those of classical CADHERINS. Their intracytoplasmic domains bind PLAKOGLOBIN; PLAKOPHILINS; and DESMOPLAKINS. ( MSH )] (UMLS (CSP) C0113214) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 87. DESTRUCT-HIP LESION NEC
- [ ] (UMLS (ICD9CM) C0177526) =Therapeutic or Preventive Procedure
|
- 38. Desmoplakin
- [Desmoplakins are cytoskeletal linker proteins that anchor INTERMEDIATE FILAMENTS to the PLASMA MEMBRANE at DESMOSOMES. ( MSH )] (UMLS (NCI) C0057555) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 88. DESTRUCT-KNEE LESION NEC
- [ ] (UMLS (ICD9CM) C0177527) =Therapeutic or Preventive Procedure
|
- 39. Desmoplakin III
- [Plakoglobin (gamma-Catenin) is a major soluble and membrane-associated cytoplasmic protein common to desmosomes and intermediate junctions. It associates with the cytoplasmic region of Desmoglein I and mediates the connection of cadherins to actin filaments and to other transmembrane and peripheral cytoplasmic proteins in epithelial adherens junctions. The cadherin-catenin complex interacts with EGFR; beta-Catenin and Plakoglobin are tyrosine phosphorylated by activated EGFR. APC binds to and regulates beta- and gamma-Catenin. Homologues of Drosophila armadillo, beta-Catenin and gamma-Catenin have analogous structures and functions in cell adhesion and the WNT signaling pathway. Several mutations of gamma-Catenin have transforming activity dependent on TCF/LEF and c-MYC function. Beta- and gamma-Catenin may have distinct roles in WNT signaling via differential effects on downstream target genes. (from OMIM 173325 and NCI) ( NCI )] (UMLS (NCI) C0137209) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 89. DESTRUCTION LID LESION
- [ ] (UMLS (ICD9CM) C0197353) =Therapeutic or Preventive Procedure ;
|
- 40. Desmoplastic Ameloblastoma
- (UMLS (NCI) C0457533) =Neoplastic Process
| - 90. Destruction of cranial and peripheral nerves
- [ ] (UMLS (ICD9CM) C0176064) =Therapeutic or Preventive Procedure
|
- 41. Desmoplastic Astrocytoma of Infancy
- [A WHO grade I large cystic tumor that occurs almost exclusively in infants, with a prominent desmoplastic stroma having a neuroepithelial population mainly of neoplastic astrocytes. It involves the superficial cerebral cortex and leptomeninges, and often attach to the dura. Although clinically it presents as large tumor, it generally has a good prognosis following surgical resection. (Adapted from WHO 2000.) ( NCI )] (UMLS (NCI) C0457179) =Neoplastic Process
| - 91. Destruction of hemorrhoids by cryotherapy
- [ ] (UMLS (ICD9CM) C0193247) =Therapeutic or Preventive Procedure
|
- 42. Desmoplastic Infantile Ganglioglioma
- [A WHO grade I large cystic tumor that occurs almost exclusively in infants, with a prominent desmoplastic stroma having a neuroepithelial population of neoplastic astrocytes together with a variable neuronal component. They involve the superficial cerebral cortex and leptomeninges, and often attach to the dura. Although clinically they present as large tumors, they generally have a good prognosis following surgical resection. (Adapted from WHO 2000.) - 2004 ( NCI )] (UMLS (NCI) C1321878) DIG =Neoplastic Process ;
| - 92. Destruction of lesion of ciliary body, nonexcisional
- [ ] (UMLS (ICD9CM) C0197663) =Therapeutic or Preventive Procedure
|
- 43. Desmoplastic Medulloblastoma
- [A medulloblastoma characterized by the presence of nodular, collagenous areas which do not contain reticulin, surrounded by hypercellular areas which contain an intercellular reticulin fiber network. ( NCI )] (UMLS (NCI) C0751291) Desmoplastic Nodular Medulloblastoma =Neoplastic Process ;
| - 93. Destruction of lesion of iris, nonexcisional
- [ ] (UMLS (ICD9CM) C0197646) =Therapeutic or Preventive Procedure
|
- 44. Desmoplastic Melanoma
- [A melanoma of the skin characterized by a proliferation of atypical spindled melanocytes in the dermis, in a background of abundant collagen. It usually presents as an amelanotic raised nodular lesion. ( NCI )] (UMLS (NCI) C1333280) =Neoplastic Process ;
| - 94. Destruction of lesion of retina and choroid
- [ ] (UMLS (ICD9CM) C0176260) =Therapeutic or Preventive Procedure
|
- 45. Desmoplastic Mesothelioma
- (UMLS (NCI) C1270206) =Neoplastic Process
| - 95. Destruction of rectal lesion or tissue by laser
- [ ] (UMLS (ICD9CM) C0176841) =Therapeutic or Preventive Procedure
|
- 46. Desmoplastic Nevus
- (UMLS (NCI) C0346098) =Neoplastic Process
| - 96. DESTRUCTION TONGUE LES
- [ ] (UMLS (ICD9CM) C0176419) =Therapeutic or Preventive Procedure
|
- 47. desmoplastic small round cell tumor
- [(dez-mo-PLAS-tik...) A rare, aggressive cancer that usually affects young males and usually is located in the abdomen. ( NCI )] (UMLS (NCI) C0281508) =Neoplastic Process
| - 97. Desulfovibrio
- [genus of gram negative, anaerobic, rod shaped bacteria capable of reducing sulfur compounds to hydrogen sulfide; organisms are isolated from anaerobic mud of fresh and salt water, animal intestines, manure, and feces. ( CSP )] (UMLS (CSP) C0011731) =Bacterium =bacteria;
|
- 48. Desmoplastic Stroma Formation
- (UMLS (NCI) C1333281) =Finding ;
| - 98. desulfurization
- [ ] (UMLS (CSP) C0599753) =Governmental or Regulatory Activity ;
|
- 49. Desmoplastic Trichilemmoma
- (UMLS (NCI) C1275206) Desmoplastic Tricholemmoma =Neoplastic Process
| - 99. Desyrel
- (UMLS (NCI) C0701914) =Organic Chemical; Pharmacologic Substance
|
- 50. Desmoplastic Trichoepithelioma
- (UMLS (NCI) C0432526) =Neoplastic Process
| |
home
